Meet Nanomi at the CRS 2010 in Portland, Oregon

Debra Bingham of Valeo Partners, Nanomi’s business development advisor in the US, will attend the CRS 2010 event in Portland, Oregon on July 10-14, 2010. We invite you to meet her and learn how Nanomi’s technology regarding size-controlled drug delivery microspheres brings value to your business. Please contact us for an appointment.

For detailed information about Nanomi please refer to our company brochure, website or contact us by email.

About Nanomi

Nanomi is an independent, privately owned Dutch life sciences company, providing its customers with novel, high added value, microsphere based (e.g. drug delivery) products enabled by its Monosphere technology™. The company was founded in 2004 and is located in the East of the Netherlands. Nanomi is profitable and has successfully entered into business agreements for the development of products for several blue chip multinationals.

The heart of the Monosphere technology is the proprietary microsieve™ emulsification process. Silicon microsieves bring the precision of the semiconductor industry to the life sciences, enabling the production of highly monodisperse droplets and particles in a robust, reproducible and cost effective way. Nanomi targets business-to-business partnerships with companies in drug delivery, molecular imaging, diagnostics, and research and analysis that have a high value product or application that can strongly benefit from its technology and does not distribute and market products on its own.

About Valeo Partners

Valeo Partners, a Washington DC-based strategy consultancy, focuses on providing strategic solutions to organizations operating in the pharmaceutical, drug delivery and biotechnology markets. Through its services in strategic planning and market research, business development, licensing, and M&A, Valeo provides senior leaders and executives the critical market insight and execution expertise needed to achieve in a competitive market place.